19-APR-2024 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 197 9 470 40 487 79 481
ERLYTX 40 1 52 3 37 8 49
GI 199 5 261 20 244 34 207
GU 511 10 522 45 548 99 603
LEUK 56 1 52 8 97 9 55
LUNG 772 14 730 73 889 161 980
LYMPH 150 3 157 19 231 39 237
MELAN 439 7 365 31 377 71 432
MMYEL 126 4 209 21 256 42 256
MULT 18 1 52 5 61 7 43
OTHER 47 1 52 2 24 10 61
PREV 4 0 0 0 0 0 0
SXQOL 4 0 0 0 0 1 6
Total 2563 56 2922 267 3251 560 3410

19-APR-2024 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 5 0 0 0 0 0 0
CCD 950 10 522 66 804 136 828
ERLYTX 8 0 0 1 12 3 18
GU 5 0 0 0 0 0 0
LUNG 363 4 209 23 280 53 323
OTHER 8 0 0 4 49 4 24
PREV 603 9 470 58 706 116 706
SURV 22 0 0 0 0 0 0
SXQOL 1520 27 1409 153 1863 310 1887
Total 3484 50 2610 305 3714 622 3786

19-APR-2024 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 202 9 470 40 487 79 481
CCD 950 10 522 66 804 136 828
ERLYTX 48 1 52 4 49 11 67
GI 199 5 261 20 244 34 207
GU 516 10 522 45 548 99 603
LEUK 56 1 52 8 97 9 55
LUNG 1135 18 939 96 1169 214 1303
LYMPH 150 3 157 19 231 39 237
MELAN 439 7 365 31 377 71 432
MMYEL 126 4 209 21 256 42 256
MULT 18 1 52 5 61 7 43
OTHER 55 1 52 6 73 14 85
PREV 607 9 470 58 706 116 706
SURV 22 0 0 0 0 0 0
SXQOL 1524 27 1409 153 1863 311 1893
Total 6047 106 5532 572 6965 1182 7196

19-APR-2024 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 125 5 261 17 207 41 250
ERLYTX 32 1 52 3 37 7 43
GI 167 4 209 17 207 27 164
GU 406 5 261 38 463 80 487
LEUK 35 0 0 5 61 6 37
LUNG 522 11 574 46 560 101 615
LYMPH 124 1 52 17 207 33 201
MELAN 267 2 104 17 207 40 244
MMYEL 88 2 104 13 158 27 164
MULT 7 0 0 1 12 2 12
OTHER 46 0 0 1 12 9 55
PREV 4 0 0 0 0 0 0
SXQOL 4 0 0 0 0 1 6
Total 1827 31 1617 175 2131 374 2278

19-APR-2024 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 5 0 0 0 0 0 0
CCD 840 8 417 54 657 117 712
ERLYTX 8 0 0 1 12 3 18
GU 5 0 0 0 0 0 0
LUNG 199 1 52 13 158 29 177
OTHER 8 0 0 4 49 4 24
PREV 405 5 261 31 377 70 426
SURV 16 0 0 0 0 0 0
SXQOL 983 18 939 99 1205 196 1193
Total 2469 32 1669 202 2458 419 2550

19-APR-2024 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 157 6 313 26 317 57 347
CCD 856 8 417 52 633 115 700
ERLYTX 40 1 52 4 49 10 61
GI 174 4 209 17 207 28 170
GU 428 7 365 39 475 84 511
LEUK 35 0 0 5 61 6 37
LUNG 721 12 626 59 718 130 791
LYMPH 124 1 52 17 207 33 201
MELAN 267 2 104 17 207 40 244
MMYEL 80 4 209 14 170 29 177
MULT 10 1 52 2 24 4 24
OTHER 62 0 0 5 61 13 79
PREV 409 5 261 31 377 70 426
SURV 16 0 0 0 0 0 0
SXQOL 987 18 939 99 1205 197 1199
Total 4366 69 3599 387 4711 816 4967

19-APR-2024 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
BREAST 143 7 365 36 438 70 426
ERLYTX 34 1 52 3 37 7 43
GI 82 2 104 9 110 14 85
GU 270 3 157 14 170 47 286
LEUK 39 1 52 6 73 7 43
LUNG 699 14 730 71 864 154 937
LYMPH 103 2 104 13 158 25 152
MELAN 4 0 0 0 0 2 12
MMYEL 105 3 157 20 244 40 244
MULT 18 1 52 5 61 7 43
Total 1497 34 1773 177 2155 373 2271

19-APR-2024 6:10

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months		 Accrual
Last
7 Days		 Yearly
Projection
(7 Days)		 Accrual
Last
30 Days		 Yearly
Projection
(30 Days)		 Accrual
Last
60 Days		 Yearly
Projection
(60 Days)
Member 1807 33 1722 173 2106 378 2301
AFFIL 200 2 104 18 219 38 231
CCOP/NCORP 2289 28 1461 186 2265 377 2295
Non-SWOG 1742 34 1774 186 2265 380 2313
Total 6038 97 5061 563 6855 1173 7140

19-APR-2024 6:10

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
GU A032101 Pros, MHSPC ADT Interruption 1 E 29-MAR-24
GU A032001 Blad, Met, Cabo +/- Avelumab after Chemo 1 E 20-MAR-24
OTHER NRGBN005 Brain, Low-Inter Grade, Proton vs Photon 1 E 19-MAR-24
OTHER NRGBN005 Brain, Low-Inter Grade, Proton vs Photon 2 E 19-MAR-24
GU S1806 Blad, MIBC, ChemoRT +/- Atezolizumab 2 N 01-APR-24

19-APR-2024 6:10

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 19
LUNG S2302 NSCLC, Stg IV or Recur, Ramu + Pembro vs SoC 1 10
MELAN S2015 MELAN, Stg I-II, 1cm v 2cm excision margins 1 7
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 6
MMYEL S1803 MM, Maintenance, Len vs Len/Dara 1 5
PREV S1823 GCT, Obs. Cohort, miRNA371 1 5
SXQOL S2010 ASPEN: Brst, Stg I-III, ASM vs Pt Ed 1 5
CCD S2108CD Genomic Tumor Board vs Usual Practice 1 5
LUNG LUNGMAP NSCLC, Adv, Master 1 4
GU EA8212 Blad, NMIBC, BRIDGE 1 3
MMYEL S1803 MM, Maintenance, Len vs Len/Dara 2 3
CCD S1912CD CREDIT, Fin Counseling to reduce Fin Hardship 1 3
LUNG S1914 NSCLC, High Risk Early Stg, SBRT +/- Atezo 1 3
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 3